Turtle Creek Wealth Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Turtle Creek Wealth Advisors's WST Position: Q3 2026 in Review
Turtle Creek Wealth Advisors reduced its West Pharmaceutical (WST) stake by 14% in Q3 2026, selling an estimated $35.7K and leaving 613 shares worth $227K. The position accounts for 0.01% of the portfolio, ranked #415.
Turtle Creek Wealth Advisors first reported a position in WST in Q4 2023 and has held it in 3 quarters since. The position peaked at $256K in Q2 2026. 881 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Turtle Creek Wealth Advisors held 613 shares of West Pharmaceutical worth $227K as of Q3 2026.
- Turtle Creek Wealth Advisors sold 101 West Pharmaceutical shares in Q3 2026, an estimated $35.7K.
- West Pharmaceutical made up 0.01% of Turtle Creek Wealth Advisors's portfolio in Q3 2026, its #415 holding.
- Turtle Creek Wealth Advisors first reported a position in West Pharmaceutical in Q4 2023 and has held it in 3 quarters since.
- Turtle Creek Wealth Advisors's West Pharmaceutical position peaked at $256K in Q2 2026.
- 881 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Turtle Creek Wealth Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.